Cytodyn Inc (CYDY)

[JPG77]

Saltz - very good points and right on the money!

"Here’s what we know. Nader did not sell shares because he wanted to reduce his exposure. Quite the opposite. He converted warrants to shares and that cost $. To cover the conversion cost he had to sell some of his shares to do so. Nader utilized a cashless exercise, also known as a same-day sale.

It's now very clear that NP did NOT liquidate any of his position. Quite the contrary, he converted warrants into shares that he now owns thus increasing his position. That on its own is a sign of confidence in the current and future valuation of Leronlimab.

On another front Remdesivir is going to be heavily scrutinized in the coming days because of Fauchi’s premature proclamation that it is now the SOC for Covid-19. The changing of the metrics of the clinical trial, no placebo arm, ineffective in meeting the initial primary endpoint of decreasing mortality, and no peer review is pulling back the sheets on a very toxic drug that appears to do nothing more than knock off a few days in the hospital if the patient survives.

The researchers changed the primary outcome that the study claimed to evaluate. Originally, the study was designed to rate participants’ health on day 15 and day 29 of treatment. Now, it’s focused on how many days it takes to recovery. There can be good reasons for changing this variable—NIAID provided an explanation on Friday, after the drug was authorized—but, without the full dataset, outside scientists can’t make sense of the change."

As usual, your DD is accurate and much appreciated!